欧洲免疫诊断市场预测至 2030 年 – 区域分析 – 按产品(酶联免疫吸附测定 (ELISA)、化学发光免疫测定 (CLIA)、放射免疫测定 (RIA) 等)、按临床适应症(传染病、肝炎+) HIV、内分泌、胃肠、代谢等)和最终用户(医院、诊所、诊断实验室、学术和研究机构等)

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2030


No. of Pages: 209    |    Report Code: BMIRE00027867    |    Category: Life Sciences

Europe Immunodiagnostics Market

欧洲免疫诊断市场预计将从2023年的61.3185亿美元增长到2030年的100.9803亿美元。预计2023年至2030年复合年增长率为7.4%。

传染病患病率的增加推动欧洲免疫诊断市场

诊断和管理由病毒、真菌、细菌、寄生虫或其有毒产物等传染原引起的几种不断增长的传染病导致免疫诊断测试的处方数量激增,例如补体结合、沉淀测试、凝集测试、线印迹分析、Western blotting印迹测定、酶免疫测定 (EIA) 和免疫荧光测试。人类免疫缺陷病毒(HIV)仍然是世界范围内的一个主要公共卫生问题。此外,结核病 (TB)、COVID-19 和其他医院获得性感染 (HAIs) 需要进行免疫诊断测试。

•  结核病已成为第 13 大死因,也是仅次于 COVID-19 的第二大传染病杀手。 2020 年,全球有 150 万人死于结核病,估计有 1000 万人受到影响,其中包括 560 万男性、330 万女性和 110 万儿童。

   据 Worldometer 称,全球报告了数百万人因 COVID-19 大流行而死亡。它给医疗保健系统带来了压力,并增加了对免疫诊断测试的需求。

诊断在确定合适的医疗方法方面发挥着至关重要的作用。免疫诊断有助于诊断严重影响免疫系统的疾病。因此,传染病患病率的上升导致对免疫诊断产品的需求激增。

欧洲免疫诊断市场概况

庞大的老年人口极大地推动了德国免疫诊断市场的发展。根据联合国人口数据,每 20 名德国人中就有 1 人年龄在 80 岁以上,预计到 2050 年,这一数字将增加到每 20 人中就有 6 人。患慢性疾病的风险,如心血管疾病 (CVD)、糖尿病、和神经血管疾病,随着年龄的增长而增加。根据罗伯特·科赫研究所2023年9月发布的德国癌症登记数据中心(ZfKD)估计,2019年德国有502,655人患有癌症,其中女性234,925人,男性267,730人。据估计,由于生活方式的改变、肥胖、不健康的习惯等,癌症的流行可能会继续下去。德国最常见的癌症是乳腺癌、前列腺癌、结直肠癌(大肠癌)、肺癌和膀胱癌。这五种癌症约占德国所有新诊断癌症的 57%。因此,癌症患病率的增加可能会推动对免疫诊断的需求。

德国是仅次于美国的世界领先的医疗生物技术国家。与新冠疫情爆发前的 2018 年相比,2020 年德国生物技术行业显着增长。过去几年,一些领域的积极市场趋势有所加速;根据BIOCOM符合OECD标准的调查显示,2020年德国生物技术产业营业额增长了近50%。老牌企业的存在和初创企业的出现肯定了产业实力。工业、政府和研究部门的蓬勃发展依赖于强大的市场基础。德国拥有众多欧洲生物技术公司、世界一流的研究基础设施和国际知名科学家,已牢固确立了其国际医疗生物技术中心的地位。德国生物技术公司推出了欧洲药品管理局批准的首个 COVID-19 检测和疫苗接种,成为 mRNA 技术的全球领导者。这些发展促进了免疫诊断技术的进步。因此,不断崛起的生物技术行业可能会提振该国的免疫诊断市场。

欧洲免疫诊断市场收入及预测至 2030 年(百万美元)

欧洲免疫诊断市场细分

欧洲免疫诊断市场分为产品、临床适应症、最终用户和国家。

根据产品,欧洲免疫诊断市场分为产品、临床适应症、最终用户和国家。免疫诊断市场分为酶联免疫吸附测定(ELISA)、化学发光免疫测定(CLIA)、放射免疫测定(RIA)等。 2023年,酶联免疫吸附测定(ELISA)领域在欧洲免疫诊断市场占据最大份额。化学发光免疫分析(CLIA)细分市场进一步细分为维生素D分析市场、HIV检测市场、HIV ag/ab组合分析市场和其他测试。

基于临床适应症欧洲免疫诊断市场细分为传染病、肝炎+艾滋病、内分泌、胃肠道、代谢等。 2023年,传染病领域在欧洲免疫诊断市场中占据最大份额。传染病细分为 COVID-19、结核病、莱姆病、感染管理、寨卡病毒、密螺旋体、火炬、麻疹和腮腺炎、水痘带状疱疹病毒和 EB 病毒。内分泌领域进一步细分为高血压、生长、糖尿病、甲状腺和生殖内分泌。

根据最终用户,欧洲免疫诊断市场细分为医院、诊所、诊断实验室、学术和实验室研究机构等。 2023年,医院细分市场在欧洲免疫诊断市场中占据最大份额。

按国家划分,欧洲免疫诊断市场分为德国、法国、英国、意大利、西班牙和欧洲其他国家。 2023年,德国市场在欧洲免疫诊断市场占据最大份额。

雅培实验室;生物梅里埃公司;丹纳赫公司; DiaSorin SpA; F.霍夫曼-拉罗氏有限公司;珀金埃尔默公司;深圳迈瑞生物医疗电子有限公司;西门子医疗保健有限公司;斯瓦尔生命科学公司;和 Thermo Fisher Scientific Inc 是欧洲免疫诊断市场上的一些领先公司。



Europe Immunodiagnostics Strategic Insights

Strategic insights for Europe Immunodiagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/europe-immunodiagnostics-market-strategic-framework.webp
Get more information on this report

Europe Immunodiagnostics Report Scope

Report Attribute Details
Market size in 2023 US$ 6,131.85 Million
Market Size by 2030 US$ 10,098.03 Million
Global CAGR (2023 - 2030) 7.4%
Historical Data 2021-2022
Forecast period 2024-2030
Segments Covered By 产品
  • 酶联免疫吸附测定
  • 化学发光免疫测定
  • 放射免疫测定
By 临床适应症
  • 传染病
  • 肝炎+艾滋病毒
  • 内分泌学
  • 胃肠道
  • 代谢
By 最终用户
  • 医院
  • 诊所
  • 诊断实验室
  • 学术和研究机构
Regions and Countries Covered 欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
Market leaders and key company profiles
  • Abbott Laboratories
  • bioMerieux SA
  • Danaher Corp
  • DiaSorin SpA
  • F. Hoffmann-La Roche Ltd
  • PerkinElmer Inc
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthcare GmbH
  • Svar Life Science AB
  • Thermo Fisher Scientific Inc
  • Get more information on this report

    Europe Immunodiagnostics Regional Insights

    The regional scope of Europe Immunodiagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-immunodiagnostics-market-geography.webp
    Get more information on this report

    The List of Companies - Europe Immunodiagnostics Market

    1. Abbott Laboratories                
    2. bioMerieux SA                             
    3. Danaher Corp                                 
    4. DiaSorin SpA                                  
    5. F. Hoffmann-La Roche Ltd           
    6. PerkinElmer Inc                               
    7. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. 
    8. Siemens Healthcare GmbH                  
    9. Svar Life Science AB                       
    10. Thermo Fisher Scientific Inc         
    Frequently Asked Questions
    How big is the Europe Immunodiagnostics Market?

    The Europe Immunodiagnostics Market is valued at US$ 6,131.85 Million in 2023, it is projected to reach US$ 10,098.03 Million by 2030.

    What is the CAGR for Europe Immunodiagnostics Market by (2023 - 2030)?

    As per our report Europe Immunodiagnostics Market, the market size is valued at US$ 6,131.85 Million in 2023, projecting it to reach US$ 10,098.03 Million by 2030. This translates to a CAGR of approximately 7.4% during the forecast period.

    What segments are covered in this report?

    The Europe Immunodiagnostics Market report typically cover these key segments-

  • 产品 (酶联免疫吸附测定, 化学发光免疫测定, 放射免疫测定)
  • 临床适应症 (传染病, 肝炎+艾滋病毒, 内分泌学, 胃肠道, 代谢)
  • 最终用户 (医院, 诊所, 诊断实验室, 学术和研究机构)
  • What is the historic period, base year, and forecast period taken for Europe Immunodiagnostics Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Immunodiagnostics Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2030
  • Who are the major players in Europe Immunodiagnostics Market?

    The Europe Immunodiagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Abbott Laboratories
  • bioMerieux SA
  • Danaher Corp
  • DiaSorin SpA
  • F. Hoffmann-La Roche Ltd
  • PerkinElmer Inc
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthcare GmbH
  • Svar Life Science AB
  • Thermo Fisher Scientific Inc
  • Who should buy this report?

    The Europe Immunodiagnostics Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Immunodiagnostics Market value chain can benefit from the information contained in a comprehensive market report.